# REported Outcomes in COPD With Trixeo in Real worlD in Germany

> **NCT05311306** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 475 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05311306
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-15
- **Primary completion:** 2024-07-16
- **Final completion:** 2024-07-16
- **Target enrollment:** 475 (ACTUAL)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05311306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05311306, "REported Outcomes in COPD With Trixeo in Real worlD in Germany". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05311306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*